View in EDS HTML Full Text PDF Full Text

CDK4/6 Inhibition and Stereotactic Radiotherapy in Oligometastatic HR+/HER2− Breast Cancer: Evidence of Immunogenic Modulation and Pseudoprogression.

Saved in:
Bibliographic Details
Title: CDK4/6 Inhibition and Stereotactic Radiotherapy in Oligometastatic HR+/HER2− Breast Cancer: Evidence of Immunogenic Modulation and Pseudoprogression.
Authors: Guerini, Andrea Emanuele1 (AUTHOR), Pedretti, Sara1,2 (AUTHOR) sara.pedretti@asst-spedalicivili.it, Carlino, Althea1,3 (AUTHOR), Maddalo, Marta1 (AUTHOR), Mataj, Eneida1,2 (AUTHOR), Pegurri, Ludovica1,3 (AUTHOR), Cossali, Gianluca1 (AUTHOR), Borghetti, Paolo1 (AUTHOR), Facheris, Giorgio1 (AUTHOR), Nicosia, Luca2 (AUTHOR), Valietti, Chiara1 (AUTHOR), Bonù, Marco Lorenzo1 (AUTHOR), Triggiani, Luca1 (AUTHOR), Buglione di Monale e Bastia, Michela1,3 (AUTHOR)
Source: Immuno. Jun2026, Vol. 6 Issue 2, p40. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:26735601
DOI:10.3390/immuno6020040